Introducing GlucoseReady™:

Transforming Cardiometabolic Clinical Trials

Experience the future of diabetes, obesity and NASH/MASH research with our integrated digital platform.

Key Features

Lifestyle & Behavioral Modification

Leveraging SPUR™ behavioral assessments and predictive analytics

Real-Time Data Capture 


Meeting new FDA guidelines
for seamless and immediate insights

Comprehensive eCOA Integration 


From patient onboarding to in-clinic visits and reporting

Advanced Biomarker Analysis

Powered by Continuous
Glucose Monitoring (CGM) and Blood Glucose Meters (BGM)

Revolutionize Your Clinical Trials
with GlucoseReady™

GlucoseReady™ is a comprehensive solution designed to revolutionize cardiometabolic disease
clinical trials. Discover how our platform empowers researchers and enhances patient outcomes
through innovation and technology.

Discover more about GlucoseReady™

Deep Dive Into GlucoseReady™: Technology, Compliance and Advanced Data Integration and Reporting

GlucoseReady™ is not just advanced; it’s precision-engineered to meet new FDA guidance and the exacting standards of today’s cardiometabolic clinical trials.

FACT SHEET

Introducing GlucoseReady™: Transforming Cardiometabolic Trials

Download our fact sheet to learn more.

Scroll to Top

Download the GlucoseReady™ White Paper

Download the GlucoseReady™ white paper and see how our platform can streamline data capture, improve retention, and ensure regulatory compliance.

Contact Clinical ink

Request more information, submit questions, set up a demonstration, and more.

Download the GlucoseReady™ Fact Sheet

Introducing GlucoseReady™: Transforming Cardiometabolic Trials